HbA1c Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes
暂无分享,去创建一个
Giuseppe Pugliese | Enzo Bonora | Gianpaolo Zerbini | E. Bonora | L. Laviola | A. Nicolucci | E. Orsi | A. Solini | G. Pugliese | O. Lamacchia | Antonio Nicolucci | S. Morano | G. Penno | Giuseppe Penno | Anna Solini | Cecilia Fondelli | Emanuela Orsi | Susanna Morano | Franco Cavalot | Olga Lamacchia | Luigi Laviola | C. Fondelli | F. Cavalot | G. Zerbini
[1] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[2] P. Home. Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes , 2005, Current medical research and opinion.
[3] A. Rigby,et al. A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes , 2008, Diabetes Care.
[4] P. Wilson,et al. Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial , 2009, Diabetes Care.
[5] A. Rigby,et al. Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT , 2009, Diabetologia.
[6] S. Shin,et al. HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study , 2012, Diabetologia.
[7] Mark Woodward,et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. , 2009, Journal of the American Society of Nephrology : JASN.
[8] D. Dunger,et al. A1C Variability as an Independent Risk Factor for Microalbuminuria in Young People With Type 1 Diabetes , 2011, Diabetes Care.
[9] Merlin C. Thomas,et al. Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11) , 2009, Diabetes Care.
[10] G. Davı̀,et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. , 1999, Circulation.
[11] R. Poveda,et al. Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] L. Laviola,et al. Rate and Determinants of Association Between Advanced Retinopathy and Chronic Kidney Disease in Patients With Type 2 Diabetes , 2012, Diabetes Care.
[13] S. Kashyap,et al. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[14] E. Bonora,et al. Diverging Association of Reduced Glomerular Filtration Rate and Albuminuria With Coronary and Noncoronary Events in Patients With Type 2 Diabetes , 2011, Diabetes Care.
[15] A. Rigby,et al. Effect of Glucose Variability on the Long-Term Risk of Microvascular Complications in Type 1 Diabetes , 2009, Diabetes Care.
[16] B. Zinman,et al. Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited , 2008, Diabetes.
[17] Matthew D. Davis,et al. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. , 2002, JAMA.
[18] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] E. Kilpatrick,et al. The rise and fall of HbA1c as a risk marker for diabetes complications , 2012, Diabetologia.
[20] F. Santilli,et al. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. , 2006, Journal of the American College of Cardiology.
[21] E. Bonora,et al. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes. , 2011, Atherosclerosis.
[22] Michael Brownlee,et al. The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes , 2007, Diabetes Care.
[23] E. Bonora,et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes , 2011, Journal of hypertension.
[24] H. Sone,et al. HbA1c variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2 , 2012, Diabetologia.
[25] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[26] Kdoqi Disclaimer. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] Jean-Paul Cristol,et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.
[28] A. Ceriello. Hypothesis: the "metabolic memory", the new challenge of diabetes. , 2009, Diabetes research and clinical practice.
[29] D. Gordin,et al. A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes , 2009, Diabetes.
[30] D. Gordin,et al. A 1 C variability predicts incident cardiovascular events , microalbuminuria , and overt diabetic nephropathy in patients with type 1 diabetes , 2009 .
[31] Matthew D. Davis,et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.
[32] Rury R Holman,et al. Risk Factors for Renal Dysfunction in Type 2 Diabetes , 2006, Diabetes.
[33] A. Nicolucci,et al. Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) study. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[34] G. Davı̀,et al. In Vivo Formation of 8-Iso-Prostaglandin F2α and Platelet Activation in Diabetes Mellitus , 1999 .